Daniela Kovacs

Dr. Daniela Kovacs


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2013 in Pigment Cell & Melanoma Research
Verified
Journal Article
Open access
PDF file
Marco d'IschiaMarco d'Ischia
Marco d'Ischia
Kazumasa WakamatsuKazumasa Wakamatsu
Kazumasa Wakamatsu
Alessandra NapolitanoAlessandra Napolitano
Alessandra Napolitano
SBStefania Briganti
Stefania Briganti
Jose Carlos Garcia-BorronJose Carlos Garcia-Borron
Jose Carlos Garcia-Borron
Shosuke ItoShosuke Ito
Shosuke Ito
Summary: Despite considerable advances in the past decade, melanin research still suffers from the lack of universally accepted and shared nomenclature, methodologies, and structural models. This paper stems from the joint efforts of chemists, biochemists, physicists, biologists, and physicians with recognized and consolidated expertise in the field of melanins and melanogenesis, who critically reviewed and experimentally revisited methods, standards, and protocols to provide for the first time a consensus set of recommended procedures to be adopted and shared by researchers involved in pigment cell research. The aim of the paper was to define an unprecedented frame of reference built on cutting‐edge knowledge and state‐of‐the‐art methodology, to enable reliable comparison of results among laboratories and new progress in the field based on standardized methods and shared information.

1 December 2005 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
GCGiorgia Cardinali
Giorgia Cardinali
SCSimona Ceccarelli
Simona Ceccarelli
DKDaniela Kovacs
Daniela Kovacs
NANicaela Aspite
Nicaela Aspite
LLLavinia Vittoria Lotti
Lavinia Vittoria Lotti
MPMauro Picardo
Mauro Picardo

19 July 2010 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
DKDaniela Kovacs
Daniela Kovacs
GCGiorgia Cardinali
Giorgia Cardinali
NAN. Aspite
N. Aspite
CCC. Cota
C. Cota
FLF. Luzi
F. Luzi
MPMauro Picardo
Mauro Picardo

1 January 2016 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
EBEmanuela Bastonini
Emanuela Bastonini
DKDaniela Kovacs
Daniela Kovacs
MPMauro Picardo
Mauro Picardo
Bastonini E, et al. Ann Dermatol. 2016 Jun;28(3):279-289. https://doi.org/10.5021/ad.2016.28.3.279

15 April 2014 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JMJ. Marie
J. Marie
DKDaniela Kovacs
Daniela Kovacs
CPC. Pain
C. Pain
TJT. Jouary
T. Jouary
CCC. Cota
C. Cota
MCM. Cario-André
M. Cario-André

21 October 2019 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
Enea Gino Di DomenicoEnea Gino Di Domenico
Enea Gino Di Domenico
SRSara Giordana Rimoldi
Sara Giordana Rimoldi
ICIlaria Cavallo
Ilaria Cavallo
GDGiovanna D’agosto
Giovanna D’agosto
ETELISABETTA TRENTO
ELISABETTA TRENTO
FEFabrizio Ensoli
Fabrizio Ensoli
Background: Infective endocarditis (IE) is associated with high rates of mortality. Prolonged treatments with high-dose intravenous antibiotics often fail to eradicate the infection, frequently leading to high-risk surgical intervention. By providing a mechanism of antibiotic tolerance, which escapes conventional antibiotic susceptibility profiling, microbial biofilm represents a key diagnostic and therapeutic challenge for clinicians. This study aims at assessing a rapid biofilm identification assay and a targeted antimicrobial susceptibility profile of biofilm-growing bacteria in patients with IE, which were unresponsive to antibiotic therapy. Results: Staphylococcus aureus was the most common isolate (50%), followed by Enterococcus faecalis (25%) and Streptococcus gallolyticus (25%). All microbial isolates were found to be capable of producing large, structured biofilms in vitro. As expected, antibiotic treatment either administered on the basis of antibiogram or chosen empirically among those considered first-line antibiotics for IE, including ceftriaxone, daptomycin, tigecycline and vancomycin, was not effective at eradicating biofilm-growing bacteria. Conversely, antimicrobial susceptibility profile of biofilm-growing bacteria indicated that teicoplanin, oxacillin and fusidic acid were most effective against S. aureus biofilm, while ampicillin was the most active against S. gallolyticus and E. faecalis biofilm, respectively. Conclusions: This study indicates that biofilm-producing bacteria, from surgically treated IE, display a high tolerance to antibiotics, which is undetected by conventional antibiograms. The rapid identification and antimicrobial tolerance profiling of biofilm-growing bacteria in IE can provide key information for both antimicrobial therapy and prevention strategies.